Aurora Cannabis - ACB Stock Forecast, Price & News

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Analysts Set New Price Targets

A number of research firms recently weighed in on ACB. ATB Capital lowered their price target on shares of Aurora Cannabis from C$5.00 to C$4.00 and set an "underperform" rating on the stock in a research report on Tuesday, May 10th. Piper Sandler decreased their price target on Aurora Cannabis from C$7.00 to C$4.00 and set a "hold" rating on the stock in a research note on Friday, May 13th. Cowen increased their price target on shares of Aurora Cannabis from C$1.85 to C$2.00 in a research report on Tuesday, July 19th. CIBC cut their target price on shares of Aurora Cannabis from C$6.50 to C$3.75 in a research note on Monday, May 16th. Finally, MKM Partners reissued a "hold" rating and issued a C$3.00 price target (down previously from C$6.50) on shares of Aurora Cannabis in a research report on Friday, May 13th. One equities research analyst has rated the stock with a sell rating and seven have issued a hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of C$3.99.

Aurora Cannabis Stock Down 5.3 %

Shares of ACB traded down C$0.13 during mid-day trading on Tuesday, reaching C$2.30. The company's stock had a trading volume of 1,072,395 shares, compared to its average volume of 2,084,364. The company's 50 day moving average is C$1.86 and its 200 day moving average is C$3.44. The stock has a market cap of C$684.82 million and a PE ratio of -0.40. Aurora Cannabis has a 12-month low of C$1.56 and a 12-month high of C$10.87. The company has a debt-to-equity ratio of 35.61, a current ratio of 5.85 and a quick ratio of 3.95.